NATALIZUMAB
natalizumab 300 mg/15 mL injection, 15 mL vial
NATALIZUMAB (9624M)
9624M
Manner of administration:Injection
Restriction 13625
Indication: Clinically definite relapsing-remitting multiple sclerosis
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 5 | DPMQ: $637.97 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Tysabri | |||||